Emerging roles of tsRNAs in programmed cell death and disease therapeutics: challenges, opportunities, and future directions
- PMID: 40809958
- PMCID: PMC12344190
- DOI: 10.1016/j.ncrna.2025.07.003
Emerging roles of tsRNAs in programmed cell death and disease therapeutics: challenges, opportunities, and future directions
Abstract
Programmed cell death (PCD), which includes various forms such as apoptosis, autophagy, necroptosis, pyroptosis, and ferroptosis, plays a pivotal role in disease pathogenesis and progression. tRNA-derived small RNAs (tsRNAs) have emerged as crucial regulators of these processes, influencing cellular fate and disease outcomes. Research has revealed diverse expression profiles of tsRNAs across various diseases, emphasizing their roles in modulating PCD pathways and their potential value in diagnosis and treatment. Specific tsRNAs can either promote or inhibit apoptosis; for example, tsRNA-3043a promotes ovarian granulosa cell apoptosis in premature ovarian insufficiency, whereas tsRNA-04002 prevents apoptosis in nucleus pulposus cells to delay intervertebral disc degeneration. Furthermore, tsRNAs serve as potential biomarkers for early disease detection, with emerging detection technologies enhancing their clinical utility. Therapeutically, tsRNA-targeted strategies, such as RNA interference and exosome-based drug delivery, offer new avenues for modulating PCD in diseases such as cancer, cardiovascular disorders, and neurodegenerative diseases. Despite challenges in understanding tsRNA biogenesis and functional diversity, their roles in regulating PCD highlight their strong potential in advancing disease diagnostics, treatment strategies, and personalized medicine.
Keywords: Clinical translation; Diagnostic biomarkers; Programmed cell death (PCD); Therapeutic targets; tsRNAs (tRNA-derived small RNAs).
© 2025 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Emerging roles of transfer RNA fragments in the CNS.Brain. 2025 Aug 1;148(8):2631-2645. doi: 10.1093/brain/awaf130. Brain. 2025. PMID: 40294208 Free PMC article. Review.
-
Transfer RNA-derived small RNAs in liver disease.Hepatobiliary Pancreat Dis Int. 2025 Jul 11:S1499-3872(25)00125-0. doi: 10.1016/j.hbpd.2025.07.001. Online ahead of print. Hepatobiliary Pancreat Dis Int. 2025. PMID: 40695636 Review.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Non-coding RNAs regulating programmed cell death and its implications in cancer chemotherapy resistance.Int J Biol Macromol. 2025 Jul;318(Pt 2):144888. doi: 10.1016/j.ijbiomac.2025.144888. Epub 2025 Jun 6. Int J Biol Macromol. 2025. PMID: 40482754 Review.
-
RNA modifications in female reproductive physiology and disease: emerging roles and clinical implications.Hum Reprod Update. 2025 Jul 1;31(4):333-360. doi: 10.1093/humupd/dmaf005. Hum Reprod Update. 2025. PMID: 40152541 Review.
References
Publication types
LinkOut - more resources
Full Text Sources